[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100612803":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":44,"collaborators":7,"id":46,"slug":7,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":7,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":7,"enrollmentInfo":54,"targetDuration":7,"studyType":57,"phases":7,"briefSummary":58,"conditions":59,"keywords":7,"overallStatus":16,"whyStopped":7,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Antonio Farina, MD","CONTACT","0512144377","antonio.farina@unibo.it",[15,28],{"facility":5,"status":16,"city":17,"state":17,"zip":18,"country":19,"cosmosGeoPoint":20,"geoPoint":25,"contacts":26},"RECRUITING","Bologna","40138","Italy",{"type":21,"coordinates":22},"Point",[23,24],11.33875,44.49381,{"lat":24,"lon":23},[27],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":19,"cosmosGeoPoint":34,"geoPoint":38,"contacts":39},"IRCCS Ca' Granda Ospedale Maggiore Policlinico","NOT_YET_RECRUITING","Milan","Milano","20122",{"type":21,"coordinates":35},[36,37],12.59836,42.78235,{"lat":37,"lon":36},[40],{"name":41,"role":11,"phone":42,"phoneExt":7,"email":43},"Irene Cetin, MD","0255032240","irene.cetin@unimi.it",{"type":45,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100612803",false,"NCT07258329","Screening for Intrapartum Fetal Compromise Using Placental Biomarkers","Screening Della Compromissione Fetale Intrapartum Mediante Utilizzo Dei Marcatori Placentari","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Gestational age ≥ 32 weeks\n* Obtaining informed consent for participation in the study and for the processing of personal data\n* Pregnant patients with an indication to perform placental marker testing as part of routine clinical practice\n* Patients who will deliver at the Obstetrics Units of the participating centers\n\nExclusion Criteria:\n\n\\- Absolute contraindications to vaginal delivery (placenta previa, vasa previa, placenta accreta, previous myomectomy)","FEMALE","18 Years",{"count":55,"type":56},428,"ESTIMATED","OBSERVATIONAL","This study aims to investigate the association between placental markers (sFlt-1, PlGF, and the sFlt-1\u002FPlGF ratio) and intrapartum fetal compromise, assessed on the basis of the cardiotocographic tracing.",[60],"Pregnant Women","2025-11-26",{"date":63,"type":64},"2025-12-02","ACTUAL",{"date":66,"type":64},"2025-03-28",{"date":68,"type":56},"2028-10-01",{"name":5,"class":6},2]